A higher pulmonary vascular resistance index during exercise, but not at rest, predicts poor clinical outcomes in adults with ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

The pulmonary valve is located between the right ventricle and the pulmonary artery. The valve acts as a doorway that lets blood into and out of the heart. Pulmonary valve stenosis is when the ...

Pulmonary rehabilitation involves following an individualized treatment plan that may include physical exercise, breathing techniques, nutritional education, and counseling. Chronic obstructive ...

The Lung Institute provides comprehensive diagnostics and treatments to patients with illnesses that affect the lungs and breathing, including lung cancer, chronic obstructive pulmonary disease, ...

The FDA approved nerandomilast tablets for adults with progressive pulmonary fibrosis, according to an industry press release ...

A pulmonary embolism is a blockage in the pulmonary artery that supplies blood to the lungs. The blockage, usually caused by a blood clot, impairs oxygenation of the blood and can damage the heart.

Crown Princess Mette-Marit of Norway is expected to undergo a lung transplant as testing indicated a "clear worsening" of her ...

Saddle pulmonary embolism describes a large blood clot that sits atop or “saddles” the main pulmonary artery where it divides and branches into the left and right lungs. It can cause breathing ...